Overview
My research focuses on evaluating novel RGD-mimetic molecules that can remodel the tumour microenvironment in lung and pancreatic cancer models. By investigating the effects of low-dose treatment on tumour vasculature and immune cell infiltration, I aim to uncover strategies that enhance the effectiveness of both immunotherapy and chemotherapy, ultimately improving treatment outcomes.